• Nasopharyngeal Carcinoma Organoid Kit
  • Human Liver Ductal Organoid Kit (Differentiation)
  • Human Liver Ductal Organoid Kit (Differentiation)
  • Nasopharyngeal Carcinoma Organoid Kit
  • Human Liver Ductal Organoid Kit (Differentiation)
  • Human Liver Ductal Organoid Kit (Differentiation)

Nasopharyngeal Carcinoma Organoid Kit

Nasopharyngeal Carcinoma Organoid Kit is a chemically defined cell culture medium for the
establishment and maintenance of human Nasopharyngeal Carcinoma organoids. Nasopharyngeal carcinoma
originates from nasopharynx epithelial cells. Patient-derived cancer organoids recapitulate the genomic and
pathological features of original tumors and therefore hold great promise for medical research and precision medicine.
$850.00
  • Nasopharyngeal Carcinoma Organoid Kit
  • Human Liver Ductal Organoid Kit (Differentiation)
  • Human Liver Ductal Organoid Kit (Differentiation)

SPECIFICATION

Organoids refer to tissue analogues with a certain spatial structure formed by three-dimensional cultivation of adult stem cells or pluripotent stem cells in vitro. Organs are highly consistent with their source tissues in terms of tissue structure, cell type, self-renewal ability, and function, thus demonstrating unique advantages in multiple biomedical fields such as developmental biology, disease modeling, precision medicine, drug research and development, gene and cell therapy, infection and immunity, and regenerative medicine.

Product Description
Nasopharyngeal Carcinoma Organoid Kit is a chemically defined cell culture medium for the
establishment and maintenance of human Nasopharyngeal Carcinoma organoids. Nasopharyngeal carcinoma
originates from nasopharynx epithelial cells. Patient-derived cancer organoids recapitulate the genomic and
pathological features of original tumors and therefore hold great promise for medical research and precision medicine.

Product Information:

Component

Component Cat#

Volume

Storage& Stability

Nasopharyngeal Carcinoma Organoid Kit Nasopharyngeal Carcinoma Organoid Kit

K2006-MLH –A100/A500

100mL/500mL

4℃,12 months

Nasopharyngeal Carcinoma   Organoid Supplement B(50x)(Differentiation)

K2006-MLH –B100/B500

2mL/10mL

-20℃,avoid repeated freeze-thaw cycles, 12 months

Nasopharyngeal Carcinoma   Organoid Supplement C(250x) (Differentiation)

K2006-MLH –C100/C500

0.4mL/2mL

-20℃, avoid repeated freeze-thaw cycles, 12 months

Nasopharyngeal Carcinoma   Organoid Supplement D(250x) (Differentiation)

K2006-MLH –D100/D500

0.4mL/2mL

-20℃, avoid repeated freeze-thaw cycles, 12 months

 

Preparation ofNasopharyngeal Carcinoma   Organoid Differentiation Medium
Use sterile technique to prepare theNasopharyngeal Carcinoma   organoid differentiation medium. mLDs grown inNasopharyngeal Carcinoma   Organoid Expansion Medium overwhelmingly consisted of cholangiocytes. After changing the Expansion Medium to differentiation medium, the mLDs could differentiate into hepatocyte like cells, which display the markers of hepatocytes, including Albumin, Ttr, Cyp3a11 and Mup20. The following examples are for preparing 10 mL of Differentiation I Medium and Differentiation II Medium. If preparing other volumes, adjust accordingly.
1.       ThawNasopharyngeal Carcinoma   Organoid Supplement B(50x) (Differentiation),Nasopharyngeal Carcinoma   Organoid Supplement C(250x) (Differentiation) andNasopharyngeal Carcinoma   Organoid Supplement D(250x) (Differentiation) on ice.
NOTE: Once thawed, use immediately or aliquot and store at -20°C for no more than 10 months. After thawing the aliquots, use immediately. Do not re-freeze.
2.       ForNasopharyngeal Carcinoma   Organoid Differentiation Medium I. Add 200 μLNasopharyngeal Carcinoma   Organoid Supplement B(50x) (Differentiation), 40 μLNasopharyngeal Carcinoma   Organoid Supplement C(250x) (Differentiation) to 10 mLNasopharyngeal Carcinoma   Organoid Basal Medium (Differentiation). Mix thoroughly.
3.       ForNasopharyngeal Carcinoma   Organoid Differentiation Medium II. Add 200 μLNasopharyngeal Carcinoma   Organoid Supplement B(50x) (Differentiation)and 40 μLNasopharyngeal Carcinoma   Organoid Supplement C(250x) (Differentiation) and 10 μLNasopharyngeal Carcinoma   Organoid Supplement D (250x) (Differentiation) to 10 mLNasopharyngeal Carcinoma   Organoid Basal Medium (Differentiation). Mix thoroughly.
NOTE: If not use immediately, store complete medium at 2-8°C for no more than 2 weeks. bioGenousTMNasopharyngeal Carcinoma   Organoid Supplement B (Differentiation) contains fungicide and antibiotics(50x). 
Protocol forNasopharyngeal Carcinoma   Organoids Differentiation
1.     Culture the mouse ductal organoids inNasopharyngeal Carcinoma   Organoid Medium(Expansion) (K2006-MLD) for at least 3 days.
2.     Change the medium toNasopharyngeal Carcinoma   Organoid Differentiation Medium I, and culture for 9 days. During this period, replace the medium every day.
3.     Change the medium toNasopharyngeal Carcinoma   Organoid Differentiation Medium II, and culture for 3 days. During this period, replace the medium every day.
4.     At the end of this period, the differentiation process is completed. The ductal organoid would differentiate into hepatocyte-like organoid with the expression of hepatic markers, such as Albumin, Ttr, Cyp3a11 and Mup20.

CONTACT US
FirstName*
LastName*
Email*
Message*